Account
Insider Insights
30.01.2024
New MHRA procedure can accelerate patient access t...

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented the Interna...

Read more
News
07.06.2023
PMA Insights: Week 23

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
14.03.2023
Newly agreed Windsor Framework carries significant...

Windsor Framework replaces the Northern Ireland protocol to address issues and provide significant c...

Read more
Insider Insights
25.01.2023
UK to introduce first-of-its-kind framework to aid...

MHRA announces UK will introduce new framework aimed at making the manufacture of innovative medicin...

Read more
News
15.12.2022
PMA Insights: Week 50

We summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...

Read more
News
24.08.2022
PMA Insights: Week 34

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
22.08.2022
MHRA awards innovation passport to a new product

The MHRA awards Innovation Passports to those products it deems innovative, in order for them to be ...

Read more
Articles
19.04.2022
Could Brexit lead to earlier access to medicines f...

Introduction Following Brexit, regulatory oversight in the UK has switched from the European Medicin...

Read more
Insider Insights
21.03.2022
Early access agreement

Patients in England will be the first in Europe to have access to Takeda’s Exkivity (mobocertinib)...

Read more
News
19.07.2021
PMA Insights: Week 29

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.